James Eberwine

From WikiMD's Medical Encyclopedia

Revision as of 18:00, 8 March 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

James Eberwine is an American neuroscientist and pharmacologist, known for his significant contributions to the field of molecular biology and neuroscience. He is currently the Elmer Holmes Bobst Professor of Systems Pharmacology and Translational Therapeutics at the University of Pennsylvania.

Early Life and Education

Eberwine was born and raised in the United States. He completed his undergraduate studies in biochemistry at the University of Illinois Urbana-Champaign. He then pursued his doctoral degree in pharmacology at the University of California, Los Angeles (UCLA), where he focused on the study of RNA and its role in the human body.

Career

After completing his doctorate, Eberwine joined the faculty at the University of Pennsylvania. His research primarily focuses on the study of gene expression in individual cells and subcellular compartments. He is particularly known for his work on single-cell RNA sequencing, a technique that allows scientists to study the gene expression of individual cells.

Eberwine's work has significantly advanced our understanding of the complexity of the human brain and the role of individual cells in health and disease. His research has implications for a wide range of neurological conditions, including Alzheimer's disease, Parkinson's disease, and schizophrenia.

Awards and Honors

Eberwine has received numerous awards and honors for his contributions to neuroscience and pharmacology. These include the McKnight Neuroscience of Brain Disorders Award, the NIH Pioneer Award, and the NIH Director's Transformative Research Award. He is also a member of the National Academy of Sciences and the American Association for the Advancement of Science.

See Also

References

<references />

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.